Farmson Basic Drugs Private Limited - Due diligence report

A 360° intelligence report on Farmson Basic Drugs Private Limited: trust score, financial health, credit view, compliance, directors, growth…

2020-01-29 Nandesari, Gujarat Active Unlisted
Share
FB Farmson Basic Drugs Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Farmson Basic Drugs Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Farmson Basic Drugs Private Limited is assessed as Moderate with a Trust Score of 68/100. Farmson Basic Drugs Private Limited is an active private limited indian non-government company incorporated in 2020, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Farmson Basic Drugs Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
71/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (800.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Compliance Score: 71/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • 1 auditor resignation(s) filed - latest: K. C. Mehta & Co. on 2022-06-06.
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
HIREN VIRENDRABHAI ZAVERI 01234567 Director 01/04/2018 6 yrs Approved
KOMAL SAMIR PATEL 01234567 Director 01/04/2018 6 yrs Approved
MILIN KAIMAS MEHTA 01234567 Director 01/04/2018 6 yrs Approved
APURVA MAHESHBHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
VINIT MENON 01234567 Director 01/04/2018 6 yrs Approved
SUDHESH ARJUN PRASAD MISHRA 01234567 Director 01/04/2018 6 yrs Approved
NARSHIBHAI K PATEL 01234567 Director 01/04/2018 6 yrs Approved
Aksh Apurva Patel 01234567 Director 01/04/2018 6 yrs Approved
Archa Ajoy Joshi 01234567 Director 01/04/2018 6 yrs Approved
  • 9 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Farmson Pharmaceutical Gujarat Private Limited
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Farmson Pharmaceutical Gujarat Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 60
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
Negative net worth.
3 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence67/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 800.00 cr already registered.
  • Compliance record supports lending.
Investor view64/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
29 Sep 2025
Charge created
Others - 250.00 cr
09 Apr 2025
Charge created
Others - 300.00 cr
28 Mar 2025
Charge created
Others - 250.00 cr
24 Feb 2025
Director appointed
Aksh Apurva Patel (Additional Director)
Director appointed
Archa Ajoy Joshi (Additional Director)
30 Sep 2024
Last AGM held
Annual general meeting
29 Sep 2024
Director ceased
MILIN KAIMAS MEHTA
Director ceased
APURVA MAHESHBHAI PATEL
31 Aug 2024
Director appointed
HIREN VIRENDRABHAI ZAVERI (Company Secretary)
31 Mar 2024
Latest balance sheet
Filed with ROC
15 Mar 2024
Director appointed
MILIN KAIMAS MEHTA (Director)
Director appointed
APURVA MAHESHBHAI PATEL (Director)
25 Oct 2023
Director ceased
SAMIR KALYANJI PATEL
29 Jan 2020
Incorporated
Registered with Roc Ahmedabad
Director appointed
KOMAL SAMIR PATEL (Director)
10

Key Observations

Auto-generated from the data above
9 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Aragen U74999TG2000PLC035826 Hyderabad, Telangana, India
Aarti Pharmalabs Limited L24100GJ2019PLC110964 Vapi, Gujarat, India
Transpek-Silox Industry U28999GJ1996PTC029188 Vadodara, Gujarat, India
Medreich U24232KA1973PLC002383 Bangalore, Karnataka, India
Technovaworld U74999MH1979PTC021599 Mumbai, Maharashtra, India
V V F U24296MH2010PLC210239 Mumbai, Maharashtra, India
Rdcconcrete U74999MH1993PLC172842 Thane, Maharashtra, India
Ppg Asian Paints U24200MH1997PTC105961 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Farmson Basic Drugs Private Limited before audits and certifications: compliance score 71/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Farmson Basic Drugs Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Farmson Basic Drugs Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Farmson Basic Drugs Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Farmson Basic Drugs Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Farmson Basic Drugs Private Limited an active company?

Farmson Basic Drugs Private Limited has MCA status “Active” with a compliance score of 71/100 (Moderate).

Is Farmson Basic Drugs Private Limited financially healthy?

Farmson Basic Drugs Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Farmson Basic Drugs Private Limited?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Farmson Basic Drugs Private Limited?

The ultimate holding entity is Farmson Pharmaceutical Gujarat Private Limited. 9 active director(s) are on record.

Does Farmson Basic Drugs Private Limited have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Farmson Basic Drugs Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 71/100 (Moderate).

Is it risky to lend to Farmson Basic Drugs Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.